HomeAI · summaries
Storia in 4 fonti
Kardigan extends biotech’s streak of big IPOs with $400M haul
Including the heart drug developer’s offering, four biotechs in 2026 have raised at least $400 million in IPO proceeds — the most in a single year since 2021, according to BioPharma Dive data.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Kardigan extends biotech’s streak of big IPOs with $400M haul
Including the heart drug developer’s offering, four biotechs in 2026 have raised at least $400 million in IPO proceeds — the most in a single year since 2021, according to…
- ·
morningstar.com
Kardigan Announces Pricing of Upsized Initial Public Offering
Kardigan Announces Pricing of Upsized Initial Public Offering
- ·
endpoints.news
Kardigan raises $400M in IPO to back three clinical-stage cardio drugs
Cardiology biotech Kardigan prices its Nasdaq IPO at $16, the top of range, raising $400M ahead of a Thursday debut.
- ·
cryptobriefing.com
Kardigan raises $400M in upsized US IPO, pricing at top of range
Kardigan raised $400 million in its upsized Nasdaq IPO, pricing at $16 per share at the top of its range, signaling renewed biotech investor appetite.